首页> 外文期刊>European Journal of Pharmacology: An International Journal >Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain.
【24h】

Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain.

机译:内源性去甲肾上腺素能基调控制神经性疼痛的脊髓神经结扎模型中的异常性疼痛症状。

获取原文
获取原文并翻译 | 示例
           

摘要

Endogenous inhibitory controls were studied in the spinal nerve ligation model of neuropathic pain. Atipamezole, a selective alpha2-adrenoceptor antagonist, produced both mechanical and cold allodynia in those rats which had not developed clear neuropathic symptoms. The same doses (50 microg i.t. or 1 mg/kg s.c.) did not increase the severity of symptoms in rats which had developed them. The opioid receptor antagonist naloxone (20 microg i.t. or 1 mg/kg s.c.) had no effect on the neuropathic symptoms. These results indicate that mechanical and cold allodynia are under endogenous noradrenergic rather than opioidergic control in this model of neuropathic pain.
机译:在神经性疼痛的脊髓神经结扎模型中研究了内源性抑制性对照。 Atipamezole(一种选择性的α2肾上腺素受体拮抗剂)在那些未表现出明显神经病性症状的大鼠中产生机械性和冷性异常性疼痛。相同剂量(50微克i.t.或1毫克/千克皮下注射)不会增加已发展为它们的大鼠的症状严重程度。阿片受体拮抗剂纳洛酮(20微克i.t.或1毫克/千克s.c.)对神经性症状没有影响。这些结果表明,在这种神经性疼痛模型中,机械性和冷性异常性疼痛属于内源性去甲肾上腺素能而不是阿片类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号